The life sciences industry is no stranger to mergers and acquisitions (M&As), helping to expand product portfolios, access new markets and pursue new innovations, amongst a myriad of other reasons. In this article, we will look at the current state of M&A activity based on data from the Biotechgate database, with insights on where the … Continue reading The Current State of M&A Activity in the Life Sciences Industry
Category: Publications & News
In this chapter we publish articles about Biotechgate as well as Biotech related topics. Also most of the articles published in newsletters are available here.
Life Sciences M&A Report: Half-Year 2023
In the first half of 2023, the slowdown in terms of global life sciences M&A deal-making experienced in the second half of 2022 has continued to show its effects. Anticipated as a year of recovery, 2023 was expected to leverage M&A as a means to adapt to rapidly changing market conditions. However, while it remains … Continue reading Life Sciences M&A Report: Half-Year 2023
Interoperability in Digital Health: Driving Innovation for Better Patient Care
Data interoperability in the digital health industry is more than just a buzzword: It stands for the potential to transform the way healthcare providers exchange electronic patient data. In this article, we will explore the importance of interoperability and the challenges it faces. Find out how to discover companies in Biotechgate that lead the development … Continue reading Interoperability in Digital Health: Driving Innovation for Better Patient Care
Financing in Digital Health: An Overview
Digital health is an industry in the life sciences experiencing constant innovation as well as attention from both investors and fellow companies. The Biotechgate Business Development Database contains an array of up-to-date information on digital health. In this article, you’ll find an overview of how funding in the industry has developed and further analysis of … Continue reading Financing in Digital Health: An Overview
The Top 5 Biggest Licensing Deals of 2023 So Far
As biotechs face a challenging commercial environment with limited options for IPOs, interest in forging partnership agreements remains high. This article explores five top biotech and pharma licensing deals, ranked by the potential total deal value, that 2023 has brought to date. From advancing precision oncology to regenerative medicine, these partnerships underscore a commitment to … Continue reading The Top 5 Biggest Licensing Deals of 2023 So Far
Biotech Product Valuation: Setting a Price for Acquisitions
Navigating the complex landscape of biotech valuations is often more of an art than a science. This article shows the methodologies and considerations implemented when assessing biotech products in a field where industry meets commerce. Big acquisitions like the purchase earlier in 2023 by Merck of Prometheus Biosciences are very good examples of how valuation … Continue reading Biotech Product Valuation: Setting a Price for Acquisitions
Venture Valuation/Biotechgate and AdvaMed Form Strategic Partnership to Drive MedTech Industry Growth
Media Release Zurich, Switzerland and Washington, D.C., USA, August 2023 – Biotechgate, a global business development and licensing database for the life sciences industry, is proud to announce its strategic partnership with the Advanced Medical Technology Association (AdvaMed). This collaboration aims to strengthen the data integration in Biotechgate, while enhancing the visibility and insight into … Continue reading Venture Valuation/Biotechgate and AdvaMed Form Strategic Partnership to Drive MedTech Industry Growth
The Impact of University Spin-offs in the Life Sciences
University spin-offs have emerged as powerful drivers of innovation and commercialization in the life sciences industry. These companies, born out of academic research, have paved the way for groundbreaking technologies and advancements that have shaped the biopharma industry. In this article, we’ll explore the impact that university spin-offs are having in the life sciences. Prominent … Continue reading The Impact of University Spin-offs in the Life Sciences
Exploring Life Science Spin-offs
The foundation of companies is a dynamic process in the life science landscape. Academic spin-offs, where research is transformed into market opportunities, as well as spin-offs from other public institutions or established companies within the industry are common pathways. For business development professionals, understanding the circumstances in which companies are founded provide valuable context: It … Continue reading Exploring Life Science Spin-offs
Breaking Down the Latest Trends in Clinical Trials: Insights from Biotechgate
Serving as the backbone of the biopharma industry, the clinical trials market is expected to reach a value of USD 84.43 billion by 2030 according to Precedence Research. The Biotechgate database lists over 780,000 trials and is continuously updated with new information for trials covering both well-known areas like oncology as well as orphan diseases … Continue reading Breaking Down the Latest Trends in Clinical Trials: Insights from Biotechgate